INTEGRATED AYURVEDIC MANAGEMENT OF KAMPAVATA IN YOUNG-ONSET PARKINSON’S DISEASE: A CASE REPORT
DOI:
https://doi.org/10.5281/zenodo.23672335Keywords:
Panchakarma; Vatavyadhi; Shamana; Shodhana; Sadyovirechana; neurodegenerative disorderAbstract
Parkinson’s disease (PD) is a slowly progressive neurodegenerative disorder characterized by resting tremor, rigidity, bradykinesia, and postural instability, along with non-motor manifestations like disturbed sleep, cognitive changes, and fatigue. In Ayurveda, Parkinson’s disease is correlated with Kampavata (Vepathu), which is a disease due to predominance of Vata Dosha.
The present case report describes an Indian male, aged 39 years, with four-year history of generalized tremors (worsened in crowds), pain in left side of body, rigidity, and disturbed sleep. His neurological examination revealed advanced-stage Young onset Parkinsonism, with his MDS-UPDRS score being 169. After limited response to allopathic management, he was admitted in Panchakarma department for Ayurvedic treatment. His Ayurvedic management was done according to classical Vatavyadhi chikitsa. The regime included Udvartana, Sarvanga Abhyanga, Nadi Swedana, Sadyovirechana, Shamana medication internally, and yoga and meditation. Post-treatment MDS-UPDRS score reduced to 100 (40.8% improvement).
Tremor intensity, rigidity, gait, and sleep were all significantly improved after treatment. The present case report shows that Panchakarma and Shamana treatment regime can produce clinically significant improvement in Parkinsonism.
Downloads
References
Agnivesha. Charka Samhita. Revised by Charka and Dridhabala. Vidyotini Hindi Commentary by Shastri K, Chaturvedi GN. Part 1. Varanasi: Chaukhambha Bharati Academy; 2020.
Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–245.
GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939–953.
Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170.
Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, Timmermann L, Van der Giessen R, Lees AJ. Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004;75(12):1672–1677.
Mathur D, Goyal K, Koul V, Anand A. The Molecular Links of Re-Emerging Therapy: A Review of Evidence of Brahmi (Bacopa monniera). Front Pharmacol. 2016;7:44.
Prabhu J, Jayakumari S, Prabhu K, Kumar JA, Subramanian M, Kavimani S. Saraswatarishta Reverses Neuronal Injury in Brain Tissues of Scopolamine-Induced Rat Model. J Anat Soc India. 2019;68(4):269–273.
Sahsrayoga. Taila Prakarana. Dhanwantaram Taila description. Kottakkal: Arya Vaidya Sala; 2011:218–220.
Sampathu D, Lee V. Parkinson’s disease. In: Principles of Molecular Medicine. 2006:1123–1129.
Singh Y, Ansari A, Singh V, Parhate S, Sharma R, Singh T. Therapeutic potential of Kalyanaka Ghrita (polyherbal-medicated Ghrita) in purview of Alzheimer’s disease: A literary review. J Drug Res Ayurvedic Sci. 2023;8:201–212.
Vaidyavarashree Basavaraj. Basavarajeeyam. Sri Govardhana Sharma, editor. 1st ed. Vatavyadhi Nidana Lakshana Chikitsa, Chapter 6. Nagpur: Gorakshana Yantralaya Publication; 1978. p.100–101.
Quinn N, Critchley P, Marsden CD. Young onset Parkinson’s disease. Mov Disord. 1987;2:73–91.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dr Sunidhi Khurana, Dr Jignesha Charel , Dr Divya B
This work is licensed under a Creative Commons Attribution 4.0 International License.
